Concordia is making new strides in health-related research — a fact confirmed by the Canadian Institutes of Health Research (CIHR), which will provide more than $500,000 in funding for two top psychology researchers. This vital support will allow Michel Dugas and Adam Radomsky to work towards new breakthroughs in treatment for anxiety and obsessive-compulsive disorders.
Both Dugas and Radomsky are members of Concordia’s newly created Centre for Clinical Research in Health (CCRH), a research group housed within the Faculty of Arts and Science. Devoted to the study of the psychosocial determinants of physical and mental health, members of the CCRH will pay particular attention to research on the causes, prevention and treatment of physical and mental health problems.
The centre’s mandate is amply evidenced by the research of Michel Dugas who, along with a team of co-investigators, will receive $383,381 over five years from CIHR for research that looks at the treatment of generalized anxiety disorder using cognitive-behavioural therapy (CBT).
For Adam Radomsky, the new funding from CIHR will also go towards using CBT in a research setting — this time, for counteracting compulsive checking in obsessive-compulsive disorder. Radomsky and his team will receive $137,483 over two and a half years from the federal granting agency and will put the funds towards research that could help reverse the effects of this serious disorder that affects more than 650,000 Canadians.
Funding for these projects is part of the federal government’s drive to make the health care system more sustainable through personalized medicine.
• Concordia Department of Psychology
• Canadian Institutes of Health Research